|
Market Closed -
Nasdaq
08:00:00 10/11/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 465.23 USD | +1.04% |
|
-0.05% | +42.14% |
| 08/11 | J&J's once-daily pill eases psoriatic arthritis symptoms in late-stage trial | RE |
| 08/11 | Trial failures of Novartis, Novo Nordisk heart drugs leave experts guessing | RE |
| Market Cap | 252B 225B 207B 188B 356B 23,588B 364B 2,473B 986B 12,628B 945B 924B 39,773B | P/E 2026 * |
24x | P/E 2027 * | 23.1x |
|---|---|---|---|---|---|
| Enterprise Value | 291B 259B 239B 217B 411B 27,250B 421B 2,856B 1,139B 14,589B 1,091B 1,068B 45,949B | EV / Sales 2026 * |
7.37x | EV / Sales 2027 * | 6.93x |
| Free-Float |
99.77% | Yield 2026 * |
2.17% | Yield 2027 * | 2.29% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AMGN | Delayed | |
CBOE
| AMGN | Real-time | |
|
Tradegate
| AMG | Real-time | |
|
Xetra
| AMG | Delayed | |
|
Boerse Muenchen
| AMG | Real-time | |
|
Deutsche Boerse AG
| AMG | Delayed | |
|
CBOE
| Real-time | ||
|
London S.E.
| 0R0T | Delayed | |
|
Borsa Italiana
| 1AMGN | End-of-day quote | |
|
Mexican S.E.
| AMGN * | End-of-day quote | |
|
Berne S.E.
| 000907582 | End-of-day quote | |
|
Wiener Boerse
| AMGN | End-of-day quote | |
|
Börse Stuttgart
| AMG | Delayed | |
|
Santiago S.E.
| AMGN | End-of-day quote | |
|
Santiago S.E.
| AMGNCL | End-of-day quote | |
|
CBOE
| 0R0T | Real-time |
Last Transcript: Amgen Inc.
| 1 day | +1.04% | ||
| 1 week | -0.05% | ||
| Current month | -0.17% | ||
| 1 month | +12.14% | ||
| 3 months | +13.21% | ||
| 6 months | +40.26% | ||
| Current year | +42.14% |
| 1 week | 447.04 |  | 483.99 |
| 1 month | 411.04 | | 483.99 |
| Current year | 318.21 | | 483.99 |
| 1 year | 312.38 | | 483.99 |
| 3 years | 253.3 | | 483.99 |
| 5 years | 198.64 | | 483.99 |
| 10 years | 138.83 | | 483.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CEO | Chief Executive Officer | 63 | 01/05/2012 |
| Director of Finance/CFO | 62 | 13/05/2010 | |
Paul Burton
CTO | Chief Tech/Sci/R&D Officer | 57 | 01/06/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CHM | Chairman | 63 | 01/01/2013 |
Tyler Jacks
BRD | Director/Board Member | 65 | 01/01/2012 |
Robert Eckert
BRD | Director/Board Member | 71 | 01/01/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/9/26 | Other | Chief Financial Officer | 34,061 | 0.0063% | ||
| 13/8/26 | Exercice | Executive/Senior Manager | 3,756 | 0.0007% | ||
| 7/8/26 | Free | Director | 85 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.04% | -0.05% | +45.29% | +76.18% | 249B | |
| +4.28% | +0.07% | +52.75% | +138.78% | 1,206B | |
| +2.13% | +4.27% | +51.21% | +91.36% | 665B | |
| +0.68% | +1.54% | +33.83% | +112.47% | 515B | |
| +2.77% | +0.98% | +49.44% | +68.46% | 381B | |
| +1.38% | +0.27% | +72.42% | +45.30% | 362B | |
| +0.29% | +1.48% | +30.84% | +58.32% | 307B | |
| +0.98% | +1.49% | +9.04% | +34.78% | 289B | |
| +1.46% | -0.59% | +42.48% | +125.82% | 207B | |
| +1.24% | +0.96% | -6.32% | -60.78% | 177B | |
| Average | +1.66% | +0.45% | +38.10% | +69.07% | 436B | |
| Weighted average by Cap. | +2.25% | +0.67% | +43.87% | +89.67% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 39.47B 35.23B 32.42B 29.42B 55.75B 3,699B 57.14B 388B 155B 1,980B 148B 145B 6,238B | 41.23B 36.8B 33.86B 30.73B 58.24B 3,864B 59.69B 405B 161B 2,069B 155B 151B 6,516B |
| Net income | 10.53B 9.4B 8.65B 7.85B 14.88B 987B 15.25B 103B 41.24B 528B 39.52B 38.68B 1,664B | 10.92B 9.75B 8.97B 8.14B 15.43B 1,024B 15.81B 107B 42.77B 548B 40.99B 40.11B 1,726B |
| Net Debt | 39.07B 34.88B 32.09B 29.13B 55.2B 3,662B 56.57B 384B 153B 1,961B 147B 144B 6,175B | 33.86B 30.22B 27.81B 25.24B 47.83B 3,174B 49.02B 333B 133B 1,699B 127B 124B 5,351B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/11/26 | USD 465.23 | +1.04% | 2,310,805 |
| 06/11/26 | USD 460.42 | +0.03% | 2,579,690 |
| 05/11/26 | USD 460.28 | -3.80% | 4,106,794 |
| 04/11/26 | USD 478.48 | +3.73% | 4,620,139 |
| 03/11/26 | USD 461.26 | -0.90% | 2,381,953 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- AMGN Stock
Select your edition
All financial news and data tailored to specific country editions
